January Shows Momentum For Canadian Cannabis Stocks

The month of January has given substantial gains to marijuana stocks mid-way through the month. As it stands the most gains have been seen in Canadian cannabis stocks to watch like Aurora Cannabis Inc. (NASDAQ: ACB). In fact, ACB stock is up over 44% since the start of 2021. This is due to investor belief that federal reform is highly likely to occur sometime this year.

The latest report from the Canadian Centre for Policy Alternatives (CCPA), titled The Golden Cushion, lists Canada’s top-paid CEOs in 2019. On average, the top-100 CEOs made 202 times what the average Canadian worker earned.

A January Rally For Top Marijuana Stocks

Move over, Miller -- it’s CBD time.

Molson Coors Beverage Co., the beer maker better known for popular brands like Coors and Miller High Life, has a new candidate for a big-time brand. But the drink, known as Veryvell, contains CBD instead of alcohol.

Pete Marino, president of the emerging growth division for Molson Coors, said in a phone interview that the company seeks to create a new mega-brand within three years. Veryvell is one of the non-alcoholic candidates from the division, which has already produced La Colombe coffee drinks and ZOA Energy drinks.

Aphria Inc. reported better-than-expected second-quarter results Thursday as the pot giant’s sales continued to grow in the competitive Canadian cannabis market. 

The Leamington, Ont.-based company said it made $160.5 million in revenue, a 33-per-cent increase from the same period a year earlier. The company also posted $12.6 million in adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA), marking a sizeable increase from the $1.9 million reported last year. 

Aphria reported a net loss of $120.6 million in the second quarter, which it attributed to rising general costs, an increase in share-based compensation, as well as expenses related to its acquisition of U.S. craft brewer Sweetwater Brewing Co. in November. 

Rubicon Organics Inc., which runs a 125,000-square-foot greenhouse cannabis greenhouse facility on 104th Street in East Ladner, this week announced it has received its first purchase order from the Société québécoise du cannabis to sell a cannabis brand exclusively for Quebec.

The brand will include both flower and hash.

Rubicon earlier said it was already ramping up production capacity to 11,000 kilograms per year of organic certified and environmentally sustainable cannabis.

The company last summer announced it received approval from Health Canada for certain site amendments.

The amendments address the expansion of the licensed area to include an 11-acre outdoor grow site on Rubicon’s 20-acre property in Delta.

Canadian marijuana company Canopy Growth (NASDAQ:CGC) will be directly active in the U.S. market inside of a year. That's according to CEO David Klein, who is banking on the environment for cannabis businesses in the U.S. to improve markedly in the proximate future.

"What we really need is some combination of SAFE Banking, a revised Cole memorandum, and a reclassification by the executive branch, all of which ... probably happens in the next six to eight months anyway," he said in an interview Friday with Canadian business news organization BNN Bloomberg.

Read entire article at Technical 420

To follow up on the first publication from a planned series of articles that are focused the global cannabis opportunity in 2021, we want to highlight the Canadian cannabis concentrate market.

In our opinion, this is an under-appreciated vertical of the Canadian cannabis market that has substantial growth prospects. Following the legalization of cannabis 2.0 products in late 2019, we noticed a substantial increase in demand for cannabis concentrates as well as products that are made by cannabis concentrates.

Clearly, for millions, a brief glance in the rear-view mirror for 2020 is best left as just that…a glance. It had been, for more than nine, long months, one of the most challenging years in recorded history. The COVID-19 pandemic, it’s path of destruction in lost lives, displaced workers and students, along with a myriad of bankrupt industries has continued to wreak havoc across the globe.

But along the way, enterprising individuals and forward-thinking companies found a way to help people cope with and actual profit from the economic downturn wrought by the novel coronavirus. And as is in all doom and gloom scenarios, there is usually a light at the end of the tunnel, and this case a safe and effective vaccine that will hopefully eradicate the virus once and for all.

Rubicon Organics Inc., which runs a 125,000-square-foot greenhouse cannabis greenhouse facility on 104th Street in East Ladner, this week announced it has received its first purchase order from the Société québécoise du cannabis to sell a cannabis brand exclusively for Quebec.

The brand will include both flower and hash.

Rubicon earlier said it was already ramping up production capacity to 11,000 kilograms per year of organic certified and environmentally sustainable cannabis.

The company last summer announced it received approval from Health Canada for certain site amendments.

The amendments address the expansion of the licensed area to include an 11-acre outdoor grow site on Rubicon’s 20-acre property in Delta.